CLASS II ONGOING Drug recall · Reported 30 Sep 2026 · FDA Enforcement Report
Menow Sunscreen Pressed Powder SPF35 PA+++, Net content recalled
Shantou Qiwei industrial is recalling Menow Sunscreen Pressed Powder SPF35 PA+++, Net content, distributed in California. The recall was initiated on 8 Aug 2026 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0854-2026
- FDA event ID
- 99625
- Recalling firm
- Shantou Qiwei industrial, Shantou
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 8 Aug 2026
- FDA classified
- 18 Sep 2026
- Reported
- 30 Sep 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Manufacturing (CGMP) Deviations
- Drug class
- Sunscreen & Personal Care
Timeline
| 8 Aug 2026 | Recall initiated by company | |
| 18 Sep 2026 | Classified by FDA | +41 days |
| 30 Sep 2026 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
cGMP Deviations
Product as listed by the FDA
MENOW SUNSCREEN PRESSED POWDER SPF35 PA+++, Net content, 9g/0.32 oz, Manufactured by: Shantzu Qiwei Industry Co. Ltd, Add: Quiwei Building, Yingloinguan, Xiashan, Chaonan district, Shantou City, Guangdong Province, China
Where it was distributed
CA only
Questions about this recall
Why was it recalled?
cGMP Deviations
Which lots are affected?
Lot #: 2024/10/11, Exp. Date 10/10/2027
Where was it sold?
CA only
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 6 Oct 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.